D.C. Mun. Regs. tit. 17, r. 17-10004

Current through Register Vol. 71, No. 49, December 6, 2024

Rule 17-10004 - INFORMED PATIENT CONSENT AND WITHDRAWAL OF PARTICIPATION

10004.1

Documented informed consent from the patient shall be obtained by the physician who authorizes the patient to participate in the collaborative practice agreement or by the pharmacist who is also a party to the collaborative practice agreement.

10004.2

For purposes of this section, documented informed consent shall mean either written consent signed by a patient, or its electronic equivalent, maintained in a patient's record.

10004.3

The patient may decline to participate or withdraw from participation at any time.

10004.4

Prior to obtaining a patient's consent to participate in a collaborative practice agreement, the physician or pharmacist, or both, shall inform a patient:

(a) Of the procedures that will be utilized for drug therapy management under the collaborative practice agreement, and such discussion shall be documented in the patient record;

(b) That the patient may decline to participate or withdraw from participating in the drug therapy management at any time; and

(c) That neither the physician nor the pharmacist has been coerced, given economic incentives, excluding normal reimbursement for services rendered, or involuntarily required to participate.

D.C. Mun. Regs. tit. 17, r. 17-10004

Final Rulemaking published at 65 DCR 8528 (8/17/2018)